REGENERON PHARMACEUTICALS's ticker is and the CUSIP is 75886F957. A total of 6 filers reported holding REGENERON PHARMACEUTICALS in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $2,139,696 | -9.8% | 2,600 | -21.2% | 0.01% | -12.5% |
Q2 2023 | $2,371,182 | -82.0% | 3,300 | -79.4% | 0.01% | -83.0% |
Q1 2023 | $13,146,720 | -7.0% | 16,000 | -18.4% | 0.05% | +42.4% |
Q4 2022 | $14,141,204 | +56.7% | 19,600 | +49.6% | 0.03% | +83.3% |
Q3 2022 | $9,024,000 | +29.4% | 13,100 | +11.0% | 0.02% | +63.6% |
Q2 2022 | $6,975,000 | -58.7% | 11,800 | -51.2% | 0.01% | -35.3% |
Q1 2022 | $16,902,000 | -40.4% | 24,200 | -46.1% | 0.02% | -26.1% |
Q4 2021 | $28,355,000 | +83.0% | 44,900 | +75.4% | 0.02% | +35.3% |
Q3 2021 | $15,493,000 | +466.1% | 25,600 | +422.4% | 0.02% | +466.7% |
Q2 2021 | $2,737,000 | -33.5% | 4,900 | -43.7% | 0.00% | -50.0% |
Q1 2021 | $4,116,000 | -81.8% | 8,700 | -81.4% | 0.01% | -84.6% |
Q4 2020 | $22,561,000 | +619.6% | 46,700 | +733.9% | 0.04% | +290.0% |
Q3 2020 | $3,135,000 | -84.1% | 5,600 | -82.3% | 0.01% | -89.0% |
Q2 2020 | $19,770,000 | +20073.5% | 31,700 | +15750.0% | 0.09% | +9000.0% |
Q1 2020 | $98,000 | -66.0% | 200 | -75.0% | 0.00% | -75.0% |
Q1 2016 | $288,000 | -33.6% | 800 | 0.0% | 0.00% | -20.0% |
Q4 2015 | $434,000 | +1450.0% | 800 | +700.0% | 0.01% | – |
Q4 2013 | $28,000 | -9.7% | 100 | 0.0% | 0.00% | -100.0% |
Q3 2013 | $31,000 | +40.9% | 100 | 0.0% | 0.00% | 0.0% |
Q2 2013 | $22,000 | – | 100 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SABBY MANAGEMENT, LLC | 2,198 | $80,686,000 | 4.69% |
SIMPLEX TRADING, LLC | 1,029 | $1,326,000 | 0.08% |
Allianz Asset Management GmbH | 205,300 | $75,364,000 | 0.07% |
Timber Hill LLC | 22,300 | $8,186,000 | 0.04% |